LJHT
ESPR

Laurie J. Hall Trustee’s Esperion Therapeutics ESPR Stock Holding History

Laurie J. Hall Trustee’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-135
Closed -$1K – 274
2022
Q4 		$1K Hold
135
– – ﹤0.01% 296
2022
Q3 		$1K Sell
135
-65
-33% -$446 ﹤0.01% 309
2022
Q2 		$1K Hold
200
– – ﹤0.01% 309
2022
Q1 		$1K Hold
200
– – ﹤0.01% 316
2021
Q4 		$1K Hold
200
– – ﹤0.01% 320
2021
Q3 		$2K Sell
200
-120
-38% -$1.75K ﹤0.01% 314
2021
Q2 		$7K Hold
320
– – ﹤0.01% 292
2021
Q1 		$9K Hold
320
– – ﹤0.01% 291
2020
Q4 		$8K Buy
320
+100
+45% +$3K ﹤0.01% 288
2020
Q3 		$8K Buy
+220
New +$8.71K ﹤0.01% 277
2019
Q4 		$10K Buy
170
+70
+70% +$3.15K ﹤0.01% 277
2019
Q3 		$4K Buy
100
+30
+43% +$1.19K ﹤0.01% 295
2019
Q2 		$3K Hold
70
– – ﹤0.01% 312
2019
Q1 		$3K Hold
70
– – ﹤0.01% 312
2018
Q4 		$3K Sell
70
-10
-13% -$482 ﹤0.01% 313
2018
Q3 		$4K Hold
80
– – ﹤0.01% 331
2018
Q2 		$3K Sell
80
-110
-58% -$5.56K ﹤0.01% 339
2018
Q1 		$14K Hold
190
– – 0.01% 265
2017
Q4 		$13K Sell
190
-90
-32% -$4.85K 0.01% 280
2017
Q3 		$14K Hold
280
– – 0.01% 233
2017
Q2 		$13K Hold
280
– – 0.01% 232
2017
Q1 		$9.99K Buy
+280
New +$6.41K 0.01% 244

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

Laurie J. Hall Trustee's ESPR Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Esperion Therapeutics (ESPR) in Q1 2023, closing a stake of 135 shares — an estimated $1K sold.

Laurie J. Hall Trustee first reported a position in ESPR in Q1 2017 and held it in 22 quarters. The position peaked at $14K in Q3 2017. 164 funds tracked by Wall St. Rank hold ESPR as of Q1 2023.

  • Laurie J. Hall Trustee reported no remaining Esperion Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 135 Esperion Therapeutics shares in Q1 2023, an estimated $1K.
  • Laurie J. Hall Trustee first reported a position in Esperion Therapeutics in Q1 2017 and held it in 22 quarters.
  • Laurie J. Hall Trustee's Esperion Therapeutics position peaked at $14K in Q3 2017.
  • 164 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.